Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo could face $6bn Avandia liability, says UBS
Glaxo could face $6bn Avandia liability, says UBS
Glaxo could face $6bn Avandia liability, says UBS
Submitted by
admin
on March 5, 2010 - 10:14am
Source:
Guardian, UK
News Tags:
GSK
Avandia
Headline:
Glaxo could face $6bn Avandia liability, says UBS
Do Not Allow Advertisers to Use My Personal information
